![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 401/04 | |
C07D 403/04 | |||
C07D 417/04 | |||
C07D 471/04 | |||
C07D 487/04 | |||
A61K 31/4164 | |||
A61K 31/426 | |||
A61P 35/00 |
(11) | Patento numeris | 3265454 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16710547.7 |
Europos patento paraiškos padavimo data | 2016-02-26 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-01-10 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/019830 |
Data | 2016-02-26 |
(87) | Numeris | WO 2016/140884 |
Data | 2016-09-09 |
(30) | Numeris | Data | Šalis |
201562127109 P | 2015-03-02 | US |
(72) |
KINSELLA, Todd, US
GELMAN, Marina, US
HONG, Hui, US
DARWISH, Ihab, S., US
SINGH, Rajinder, US
YU, Jiaxin, US
BORZILLERI, Robert, M., US
VELAPARTHI, Upender, US
LIU, Peiying, US
DARNE, Chetan, US
RAHAMAN, Hasibur, IN
WARRIER, Jayakumar, Sankara, IN
|
(73) |
Rigel Pharmaceuticals, Inc.,
1180 Veterans Boulevard, South San Francisco, CA 94080,
US
Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US |
(54) | TGF-BETA INHIBITORS |
TGF-BETA INHIBITORS |